Read + Share
Amedeo Smart
Independent Medical Education
Harrison SA, Baum SJ, Gunn NT, Younes ZH, et al. Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease. Am J Gastroenterol 2021;116:2399-2409.PMID: 34382947
Email
LinkedIn
Facebook
Twitter
Privacy Policy